Consistent Downstream Demand Drives the German Levofloxacin Hemihydrate Prices

Hamburg, Germany: Levofloxacin Hemihydrate prices continue to observe an upward price trajectory in Germany with the start of November 2022 due to healthy downstream demand. The prices of Levofloxacin Hemihydrate inclined since October 2022, showing an inclination of 3.56 percent owing to higher customer inquiries and traders. However, higher energy costs and congestion at the ports of Germany support this increased price trend.

The surge in Levofloxacin Hemihydrate prices further propelled the suppliers to increase their stock level and maintain the increased demand considerably. Higher energy costs increase the operation charges, which in turn propel the pricing propensity of Levofloxacin Hemihydrate in Germany. Also, soaring inflation rate and supply disruption at the ports of Europe stimulate the Levofloxacin Hemihydrate market to remain on the upper end.

Furthermore, a continuous Russian-Ukraine war, a rise in German inflation, and challenges in the logistics sector, such as port bottlenecks and continuous labor deficit, are also causing a substantial scarcity of vehicles and drivers in the region. The delayed shipments and yard occupancy has grown due to the queue of cargoes waiting to be loaded and discharged, which shows another factor of upsurged cost of Levofloxacin Hemihydrate in the market. The imposition of strict covid policies in China (primarily an exporter) significantly affects the production and trading activities in various other regions, including Germany. Overall, the prices of Levofloxacin Hemihydrate recorded were inclined by 4.34 percent in Germany.

According to ChemAnalyst, "The Levofloxacin Hemihydrate price trend is expected to showcase a downward trend in December 2022. Higher stock levels with market players are likely to witness in the domestic market. Additionally, trading activities will likely remain on the weaker side in the upcoming month. Further, inquiries from customers stay on the lower side, which is likely to support the weak market sentiments of Levofloxacin Hemihydrate in Germany."